Literature DB >> 18583715

Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model.

Nicoletta Rizzi1, Nian Liu, Carlo Napolitano, Alessandra Nori, Federica Turcato, Barbara Colombi, Silvio Bicciato, Diego Arcelli, Alessandro Spedito, Mario Scelsi, Laura Villani, Giovanni Esposito, Simona Boncompagni, Feliciano Protasi, Pompeo Volpe, Silvia G Priori.   

Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmogenic disorder characterized by life threatening arrhythmias elicited by physical and emotional stress in young individuals. The recessive form of CPVT is associated with mutation in the cardiac calsequestrin gene (CASQ2). We engineered and characterized a homozygous CASQ2(R33Q/R33Q) mouse model that closely mimics the clinical phenotype of CPVT patients. CASQ2(R33Q/R33Q) mice develop bidirectional VT on exposure to environmental stress whereas CASQ2(R33Q/R33Q) myocytes show reduction of the sarcoplasmic reticulum (SR) calcium content, adrenergically mediated delayed (DADs) and early (EADs) afterdepolarizations leading to triggered activity. Furthermore triadin, junctin, and CASQ2-R33Q proteins are significantly decreased in knock-in mice despite normal levels of mRNA, whereas the ryanodine receptor (RyR2), calreticulin, phospholamban, and SERCA2a-ATPase are not changed. Trypsin digestion studies show increased susceptibility to proteolysis of mutant CASQ2. Despite normal histology, CASQ2(R33Q/R33Q) hearts display ultrastructural changes such as disarray of junctional electron-dense material, referable to CASQ2 polymers, dilatation of junctional SR, yet normal total SR volume. Based on the foregoings, we propose that the phenotype of the CASQ2(R33Q/R33Q) CPVT mouse model is portrayed by an unexpected set of abnormalities including (1) reduced CASQ2 content, possibly attributable to increased degradation of CASQ2-R33Q, (2) reduction of SR calcium content, (3) dilatation of junctional SR, and (4) impaired clustering of mutant CASQ2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583715     DOI: 10.1161/CIRCRESAHA.108.171660

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  66 in total

Review 1.  Inherited calcium channelopathies in the pathophysiology of arrhythmias.

Authors:  Luigi Venetucci; Marco Denegri; Carlo Napolitano; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

2.  The catecholaminergic polymorphic ventricular tachycardia mutation R33Q disrupts the N-terminal structural motif that regulates reversible calsequestrin polymerization.

Authors:  Naresh C Bal; Ashoke Sharon; Subash C Gupta; Nivedita Jena; Sana Shaikh; Sandor Gyorke; Muthu Periasamy
Journal:  J Biol Chem       Date:  2010-03-30       Impact factor: 5.157

3.  In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation.

Authors:  Biyi Chen; Ang Guo; Zhan Gao; Sheng Wei; Yu-Ping Xie; S R Wayne Chen; Mark E Anderson; Long-Sheng Song
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-06-21

Review 4.  Ca(2+) signaling in striated muscle: the elusive roles of triadin, junctin, and calsequestrin.

Authors:  Nicole A Beard; Lan Wei; Angela Fay Dulhunty
Journal:  Eur Biophys J       Date:  2009-05-12       Impact factor: 1.733

Review 5.  Store overload-induced Ca2+ release as a triggering mechanism for CPVT and MH episodes caused by mutations in RYR and CASQ genes.

Authors:  David H MacLennan; S R Wayne Chen
Journal:  J Physiol       Date:  2009-07-01       Impact factor: 5.182

Review 6.  Cardiac calsequestrin: quest inside the SR.

Authors:  Sandor Györke; Sarah C W Stevens; Dmitry Terentyev
Journal:  J Physiol       Date:  2009-07-01       Impact factor: 5.182

7.  Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice.

Authors:  Marco Dainese; Marco Quarta; Alla D Lyfenko; Cecilia Paolini; Marta Canato; Carlo Reggiani; Robert T Dirksen; Feliciano Protasi
Journal:  FASEB J       Date:  2009-02-23       Impact factor: 5.191

Review 8.  Gene therapy to treat cardiac arrhythmias.

Authors:  Rossana Bongianino; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2015-04-28       Impact factor: 32.419

9.  Slow Calcium-Depolarization-Calcium waves may initiate fast local depolarization waves in ventricular tissue.

Authors:  Aslak Tveito; Glenn Terje Lines; Andrew G Edwards; Mary M Maleckar; Anushka Michailova; Johan Hake; Andrew McCulloch
Journal:  Prog Biophys Mol Biol       Date:  2012-07-24       Impact factor: 3.667

10.  Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass.

Authors:  Fredrick A Hilliard; Derek S Steele; Derek Laver; Zhaokang Yang; Sylvain J Le Marchand; Nagesh Chopra; David W Piston; Sabine Huke; Björn C Knollmann
Journal:  J Mol Cell Cardiol       Date:  2009-10-14       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.